LFGAX | Focused Growth Fund Class A | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Focused Growth Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Focused Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of U.S. companies.

Fund Basicsas of 05/31/2024

Total Net Assets
$54.64 M
Inception Date
02/01/2019
Dividend Frequency
Annually (Daily Accrual)
Fund Gross Expense Ratio
1.70%
Fund Net Expense Ratio
1.05%
Number of Holdings
34
Minimum Initial Investment
$1,500+

TEN LARGEST HOLDINGS as of 04/30/2024View Portfolio

Holding Assets
NVIDIA Corp 11.3%
Amazon.com Inc 7.3%
Microsoft Corp 6.6%
Alphabet Inc 5.1%
Eli Lilly & Co 3.9%
Meta Platforms Inc 3.9%
Spotify Technology SA 3.7%
Shopify Inc 3.5%
Intuitive Surgical Inc 3.2%
Uber Technologies Inc 2.9%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner, Portfolio Manager

37 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

23 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

23 Years of Industry Experience

Supported By 43 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 1.70%

Net 1.05%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 01/31/2019
w/o sales charge 16.13% 34.29% 2.05% 16.93% - 16.94%
Lipper Category Avg. Large-Cap Growth Funds 12.91% 32.64% 7.35% 16.23% - -
Russell 1000® Growth Index 13.08% 33.60% 11.12% 19.37% - 19.01%
w/ sales charge 9.46% 26.58% 0.05% 15.56% - 15.64%

Fund Expense Ratio :

Gross 1.70%

Net 1.05%

Fund Expense Ratio :

Gross 1.70%

Net 1.05%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 01/31/2019
w/o sales charge 17.34% 40.89% 3.43% 16.83% - 17.77%
Lipper Category Avg. Large-Cap Growth Funds 12.37% 39.20% 9.06% 15.68% - -
Russell 1000® Growth Index 11.41% 39.00% 12.50% 18.52% - 19.34%
w/ sales charge 10.59% 32.75% 1.41% 15.45% - 16.42%

Fund Expense Ratio :

Gross 1.70%

Net 1.05%

Year Fund Returns Russell 1000® Growth Index
2023 33.80% 42.68%
2022 -39.06% -29.14%
2021 12.94% 27.60%
2020 86.10% 38.49%
Year Q1 Q2 Q3 Q4
2024 17.34% - - -
2023 11.43% 10.96% -5.21% 14.16%
2022 -13.02% -24.49% -1.91% -5.41%
2021 -2.35% 9.65% -0.06% 5.55%
2020 -7.20% 41.99% 21.17% 16.56%

Growth of $10,000 as of 05/31/2024

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioningas of 03/31/2024

  • We believe the pressure on stock market valuations from the post-pandemic inflation surge and the Fed’s aggressive tightening is at an end, removing a major headwind for innovation stocks. While the decline in inflation has not been linear, several indicators suggest a continued downward bias. The remaining exception being a strong labor market, which has mixed implications, as higher real wages support consumer spending and a soft landing, while higher service prices should keep the Fed vigilant. Against this backdrop, we see stable economic growth and a low probability of a severe recession.

  • Thus far in 2024, unique areas of the U.S. economy are seeing differentiated growth and operating momentum relative to the broader market, creating a large dispersion in stock performance. The “Magnificent 7” from 2023 has given way to a much broader set of secular winners across and within industries. We continue to focus on these companies, as we believe their expanding markets, combined with market-share gains, pricing power, and efficiency-driven margin expansion, support above average revenue and earnings growth despite a modestly mixed and evolving global macro backdrop. At some point soon, we also envision a great number of smaller capitalized stocks to begin to outperform after a long period of underperformance.

  • Looking ahead, we are focused on several themes that we believe provide attractive long-term growth potential due to secular forces at play. These include, but are not limited to, generative artificial intelligence, the continued shift from offline consumption to online services, the proliferation of and improved use cases within medical devices, revolutionary advances in medical treatments and genomics technology, an industrial infrastructure reinvestment cycle driven by datacenter, electric grid, and supply chain reshoring, and a continuation of innovation in our consumer society. We are levered to these themes across our portfolios through companies that are seeing outsized growth because of one or more of these durable trends

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 06/21/2024

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $50,000 5.75% 5.00% $31.78
$50,000 to $99,999 4.75% 4.00% $31.44
$100,000 to $249,999 3.95% 3.25% $31.18
$250,000 to $499,999 2.75% 2.25% $30.80
$500,000 to $999,999 1.95% 1.75% $30.55
$1,000,000 to $5,000,000 0.00% 1.00% $29.95

EXPENSE RATIOas of 05/31/2024

Fund Gross Expense Ratio Fund Net Expense Ratio
1.70% 1.05%

Fund Documents

Fund Documents

0Documents selected
Portfolio Holdings 1Q
Publish Date:11/03/2015
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field